Patents by Inventor Bo-Ram Lim

Bo-Ram Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11979453
    Abstract: A robot control system and a method may be operated in a microservices architecture (MSA)-based control environment. The robot control system includes an application programming interface (API) gateway that connects an authentication server for authenticating a robot, a management server for managing the robot, and an operation server for operating the robot in a Hyper Text Transfer Protocol (HTTP) communication method and an administrator terminal that communicates with the robot through WebRTC (Web Real-Time Communication).
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: May 7, 2024
    Assignees: Hyundai Motor Company, Kia Corporation
    Inventors: Ga Hee Kim, Bo Ram Kim, Gil Jin Yang, Jung Min Ryu, Jae Hag Jung, Il Yong Yoon, Chan Mo Lim
  • Patent number: 11421200
    Abstract: The present disclosure relates to a microorganism of the genus Corynebacterium producing a purine nucleotide and a method for producing a purine nucleotide using the same.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: August 23, 2022
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Hee Ju Kim, Bo Ram Lim, Byoung Hoon Yoon, Min Ji Baek, Ji Hye Lee
  • Publication number: 20200347346
    Abstract: The present disclosure relates to a microorganism of the genus Corynebacterium producing a purine nucleotide and a method for producing a purine nucleotide using the same.
    Type: Application
    Filed: January 25, 2019
    Publication date: November 5, 2020
    Inventors: Hee Ju KIM, Bo Ram LIM, Byoung Hoon YOON, Min Ji BAEK, Ji Hye LEE
  • Publication number: 20070287180
    Abstract: The present invention relates to Escherichia coli variants that have increased antibiotics susceptibility, diffusion efficiency, and transformation efficiency. The variants can minimize the problems caused by biofilm formation such as increased resistance to antibiotics, decreased solute diffusion efficiency, and lowered transformation efficiency. According to the present invention, when selecting genetically-modified E. coli variants, not only a lesser amount of antibiotics is required when selecting desirable variants, but also the reduction of selection efficiency caused by biofilm formation by strains other than the variants to be selected, thus decreasing exhibiting resistance to antibiotics, can be avoided. Additionally, in the process of materials production, the amount of secreted products could be increased due to the increased solute diffusion efficiency. Furthermore, the increased transformation efficiency makes the mass production of useful materials easier.
    Type: Application
    Filed: September 1, 2005
    Publication date: December 13, 2007
    Inventors: Sun-Chang Kim, Choong-Hoon Lee, Bo-Ram Lim, Bong-Hyun Sung, Byung-Jo Yu, Won-Sik Lee, Jun-Hyoung Lee, Sang-Hee Lee